NeuroSense Therapeutics Ltd.
Stock Forecast, Prediction & Price Target

NeuroSense Therapeutics Ltd. Financial Estimates

NeuroSense Therapeutics Ltd. Revenue Estimates

NeuroSense Therapeutics Ltd. EBITDA Estimates

NeuroSense Therapeutics Ltd. Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $11.47M
Low: $11.47M
High: $11.47M
avg. 0%
Avg: $23.07M
Low: $23.07M
High: $23.07M
avg. 101.10%
Avg: $37.13M
Low: $37.13M
High: $37.13M
avg. 60.89%
Net Income
 
% change YoY
$-2.49M
 
N/A
$-11.19M
 
-348.77%
$-10.10M
 
9.73%
Avg: $-15.17M
Low: $-10.91M
High: $-8.32M
avg. -50.09%
Avg: $-8.11M
Low: $-4.63M
High: $-4.63M
avg. 46.49%
Avg: $1.50M
Low: $1.50M
High: $1.50M
avg. 118.48%
Avg: $7.91M
Low: $7.91M
High: $7.91M
avg. 427.27%
EBITDA
 
% change YoY
$-8.28M
 
N/A
$-13.37M
 
-61.50%
$-10.63M
 
20.52%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$1.29
 
N/A
-$0.97
 
24.80%
-$0.83
 
14.43%
Avg: -$0.71
Low: -$0.8
High: -$0.61
avg. 15.06%
Avg: -$0.34
Low: -$0.34
High: -$0.34
avg. 51.77%
Avg: $0.11
Low: $0.11
High: $0.11
avg. 132.35%
Avg: $0.58
Low: $0.58
High: $0.58
avg. 427.27%
Operating Expenses
 
% change YoY
$5.58M
 
N/A
$13.55M
 
142.56%
$10.28M
 
-24.10%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is NeuroSense Therapeutics Ltd. stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 135.54% in 2025-2028.

We have gathered data from 1 analysts. Their low estimate is -10.91M, average is -15.17M and high is -8.32M.

What is NeuroSense Therapeutics Ltd. stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 40.50% in 2025-2028.

We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is NeuroSense Therapeutics Ltd. stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 156.61% in 2025-2028.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.8, average is -$0.71 and high is $-0.61.